Entries by Site Administrator

The International Cannabinoid Research Society (ICRS) has adopted the journal Cannabis and Cannabinoid Research (CCR)

By Fred Gardner The International Cannabinoid Research Society (ICRS) has adopted the journal Cannabis and Cannabinoid Research (CCR) as its official publication. Dr. Daniele Piomelli, a pharmacologist at UC Irvine, edits the journal.

The press release from the publisher states that CCR is “extremely excited” by the affiliation. The release does not list clinical among the types of studies the ICRS has been “spearheading,” but does list “misuse potential.”

“Beyond CBD” makes its entrance as a supplement to the peer-reviewed journal Alternative

A note from the publisher of Alternative Therapies in Health and Medicine introduces “the first issue of Beyond CBD, a special supplement.” They’re obviously planning more. The lead article, “The Endocannabinoid System and its Modulation by Cannabidiol (CBD)” by Jamie Corroon, ND, MPH, and Jake F. Felice, ND, LMP is the most thorough and well-written overview we’ve seen.

,

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.

Authors: Elisabeth G. Celius, Carlos Vila
Brain and Behavior, 6 April 2018

BACKGROUND: Driving ability is a key function for the majority of patients with multiple sclerosis (MS) to help maintain daily interactions. Both physical and cognitive disability, as well as treatments, may affect the ability to drive. Spasticity is a common symptom associate…

Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.

Authors: Dacai Xu, Jianglin Wang, Zhenkang Zhou, Zhiwei He, Qing Zhao
Molecular Medicine Reports, December 2015

Hepatocellular carcinoma (HCC) is the leading cause of cancer-associated mortality worldwide; however, only limited therapeutic treatments are currently available. The present study aimed to investigate the effects of cannabinoids as novel therapeutic targets in HCC. In additi…

Cannabinoids and Epilepsy.

Authors: Evan C. Rosenberg, Richard W. Tsien, Benjamin J. Whalley, Orrin Devinsky
Neurotherapeutics, October 2015

Cannabis has been used for centuries to treat seizures. Recent anecdotal reports, accumulating animal model data, and mechanistic insights have raised interest in cannabis-based antiepileptic therapies. In this study, we review current understanding of the endocannabinoid syst…

Endocannabinoid Signaling in Autism.

Authors: Bhismadev Chakrabarti, Antonio Persico, Natalia Battista, Mauro Maccarrone
Neurotherapeutics, October 2015

Autism spectrum disorder (ASD) is a complex behavioral condition with onset during early childhood and a lifelong course in the vast majority of cases. To date, no behavioral, genetic, brain imaging, or electrophysiological test can specifically validate a clinical diagnosis o…

Marijuana Use in Epilepsy: The Myth and the Reality.

Authors: Kamil Detyniecki, Lawrence Hirsch
Current Neurology and Neuroscience Reports, October 2015

Marijuana has been utilized as a medicinal plant to treat a variety of conditions for nearly five millennia. Over the past few years, there has been an unprecedented interest in using cannabis extracts to treat epilepsy, spurred on by a few refractory pediatric cases featured…